Publicaciones en colaboración con investigadores/as de Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (13)

2023

  1. Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia

    Haematologica, Vol. 108, Núm. 10, pp. 2652-2663

2022

  1. FPR2 DNA Aptamers for Targeted Therapy of Wound Repair

    Journal of Investigative Dermatology, Vol. 142, Núm. 8, pp. 2238-2248.e8

2021

  1. Functional specificity of the members of the sos family of ras‐gef activators: Novel role of sos2 in control of epidermal stem cell homeostasis

    Cancers, Vol. 13, Núm. 9

  2. Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposes

    Molecular Therapy - Methods and Clinical Development, Vol. 22, pp. 66-75

  3. Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes

    HemaSphere, Vol. 5, Núm. 4

2015

  1. Chemokines and relapses in childhood acute lymphoblastic leukemia: A role in migration and in resistance to antileukemic drugs

    Blood Cells, Molecules, and Diseases, Vol. 55, Núm. 3, pp. 220-227

  2. The NFKB Inducing Kinase Modulates Hematopoiesis during Stress

    Stem Cells, Vol. 33, Núm. 9, pp. 2825-2837

2011

  1. Chromosome fragility in patients with Fanconi anaemia: Diagnostic implications and clinical impact

    Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 242-250

2009

  1. Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from fanconi anemia patients

    Molecular Therapy, Vol. 17, Núm. 6, pp. 1083-1092

2007

  1. A comprehensive strategy for the subtyping of patients with Fanconi anaemia: Conclusions from the Spanish Fanconi Anemia Research Network

    Journal of Medical Genetics, Vol. 44, Núm. 4, pp. 241-249

2006

  1. A simplified approach to improve the efficiency and safety of ex vivo hematopoietic gene therapy in fanconi anemia patients

    Human Gene Therapy, Vol. 17, Núm. 2, pp. 245-250

2005

  1. Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors

    Cancer Gene Therapy, Vol. 12, Núm. 4, pp. 341-349

2003

  1. Transplantation of marrow cells from children with standard risk-acute lymphoblastic leukemia at the end of therapy into NOD/SCID mice for detecting residual leukemic cells with in vivo growth potential

    Leukemia Research, Vol. 27, Núm. 12, pp. 1153-1157